Turnstone Biologics Raises $80 Million for Series D

Turnstone Biologics Raises $80 Million for Series D

For more information, please visit www.turnstonebio.com, and follow Turnstone on LinkedIn.

Turnstone Biologics, a privately held clinical stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading platforms, both independently and in combination, that drive innate and adaptive tumor immunity to provide benefit to the millions of cancer patients underserved by current treatment options. Turnstone’s proprietary vaccinia virus platform is engineered to drive coordinated immune activation, potent viral activity and local expression of encoded therapeutics. The Company has an ongoing Phase 1/2a trial in solid tumors (RAPTOR) for its leading oncolytic virus candidate, RIVAL-01/TAK-605, which is being developed under a global collaboration with Takeda. The novel TIL therapy platform leverages clinically validated treatment protocols and has been specifically designed to extend beyond the use of bulk TILs to enrich for the most relevant T-cells for tumor eradication, preserving broad antigen diversity and minimizing time to treatment for patients. Turnstone is expecting the lead TIL therapy candidate, TIDAL-01, to enter the clinic by early 2022.

Concurrent with the financing, Santhosh Palani, Ph.D., CFA, Partner at PFM Health Sciences, will join the Company’s Board of Directors. “The addition of the TIL therapy platform to Turnstone’s existing viral immunotherapy creates a significant strategic advantage for the Company,“ said Dr. Palani. “Turnstone’s TIL programs represent the most direct approach to advance the field as there is strong clinical evidence that selection of tumor reactive T-cells can drive better patient outcomes. The enhanced benefit and curative potential that Turnstone can uniquely bring by combining viral immunotherapy with TILs to solve challenges associated with solid tumors, drives yet another layer of excitement.”

Turnstone’s lead TIL therapy candidate, TIDAL-01, is expected to enter clinical development by early next year. The program builds on clinically validated treatment protocols while enriching for the most relevant T-cells for tumor eradication, preserving broad antigen diversity, and minimizing time to treatment for patients, with the ultimate goal of extending the benefit of TIL therapy across a wider range of solid tumor types.

About Turnstone Biologics

Proceeds from the financing will be used to advance Turnstone’s pipeline of programs from its oncolytic virus and TIL therapy platforms. Turnstone’s lead oncolytic virus candidate, RIVAL-01/TAK-605, is currently in the dose escalation stage of a Phase 1/2a clinical study in solid tumors conducted in collaboration with Takeda Pharmaceutical Company Limited (“Takeda”). The product is derived from the Company’s proprietary vaccinia virus platform that has been engineered for enhanced immune-stimulation and tumor cell selectivity, large transgene carrying capacity for local expression of encoded therapeutics, and with flexibility for both intratumoral and intravenous delivery.

The News Highlights

  • Turnstone Biologics Raises $80 Million for Series D
  • Check the latest News news updates and information about business, finance and more.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
cold hole Technology Closes $14M Financing
cold hole Technology Closes $14M Financing
Commenting on their 19th investment to date, CBGF CEO, George Rossolatos shared, “We are proud to back Brett and the Cold Bore team alongside bp ventures as ...
ONC wants contributions on the structure of the Qualified Health Information Network
ONC wants contributions on the structure of the Qualified Health Information Network
ON THE RECORD”The publication of the draft QTF for feedback is an important milestone as we look to live, in production, exchange under the Common Agreement in ...
GameStop to rebrand EB games in Canada
GameStop to rebrand EB games in Canada
One such example of this was Target exclusives, which immediately posed a problem in Canada, where Target stores had existed when amiibo first launched, but ...
Next-Gen GTA 5 Leaks Indicate Single-Player Save Transfers
Next-Gen GTA 5 Leaks Indicate Single-Player Save Transfers
We don’t know a whole lot about the next-gen port, other than the assumption that it will be called Expanded and Enhanced, that it will bring with it new ...
White House says COVID’s eviction moratorium will expire on Saturday after Supreme Court ruling
White House says COVID’s eviction moratorium will expire on Saturday after Supreme Court ruling
“In light of the Supreme Court’s ruling, the president calls on Congress to extend the eviction moratorium to protect such vulnerable renters and their ...
‘Neo: The World Ends With You’ Review
‘Neo: The World Ends With You’ Review
There’s a lot to like in “Neo: The World Ends With You,” from its wacky urban fantasy story that aptly infuses outlandish plot devices into contemporary ...
Liberty company owner says, man, Salvador Perez-Merino, broke restaurant windows after eviction and layoff
Liberty company owner says, man, Salvador Perez-Merino, broke restaurant windows after eviction and layoff
Police said after Perez-Marino was arrested, he attempted to get out of his handcuffs and cursed at the officer. As police were leaving, Perez-Merino arrived ...
Biden will ask states to provide $100 in payments for newly vaccinated people
Biden will ask states to provide $100 in payments for newly vaccinated people
“It’s going to spread through unvaccinated workplaces and classrooms, resulting in a loss of productivity, where parents and caregivers cannot go to work due ...
Delta variant ‘absolutely’ leading Covid’s innovative cases, says doctor
Delta variant ‘absolutely’ leading Covid’s innovative cases, says doctor
“The athletes that have gotten Covid, despite being vaccinated, by and large, returned and have done well and been able to return and perform at a high ...
Xavien Howard asked Dolphins to transfer future money to 2021
Xavien Howard asked Dolphins to transfer future money to 2021
But transitioning $4M in base salary from down the road and moving it to the here and now is a very, very easy solution. And it is one that can be easily ...
Show next
Compsmag - Latest News from tech, business and health
Logo